Non-Valvular Atrial Fibrillation: A Systematic Review

Authors

  • Mehraj Sharik Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India https://orcid.org/0000-0001-8357-5130
  • Wani Mubashir Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India https://orcid.org/0000-0002-8390-5272
  • Wani Abdul Ahad Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India
  • Aamir Shafi Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India https://orcid.org/0000-0002-9930-1828

Abstract

Non-Valvular atrial fibrillation is defined as the one which develops in the absence of moderate to severe rheumatic mitral stenosis ,a mechanical or bioprosthetic valve or mitral valve repair. Atrial fibrillation is the most common pathological cardiac arrhythmia and major cause of ischemic stroke. There are many major risk factors for development of atrial fibrillation. Among these advanced age, hypertension, ischemic heart disease, chronic lung disease and consumption of alcohol are the major causes. Aim of treatment is to control the rate, rhythm and anticoagulation so as to prevent tachycardia induced cardiomyopathy, heart failure and stroke. This review article gives a comprehensive and systematic approach for the management of Non-valvular atrial fibrillation.

Keywords: Atrial fibrillation (AF), Stroke, Anticoagulation.

Keywords:

Atrial fibrillation (AF), Stroke, Anticoagulation

DOI

https://doi.org/10.22270/jddt.v12i4-S.5522

Author Biographies

Mehraj Sharik, Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Wani Mubashir, Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Wani Abdul Ahad, Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Aamir Shafi, Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

Department of General Medicine, Sheri Kashmir Institute of Medical Science, Bemina Srinagar (Jammu and Kashmir) India

References

Pritchett EL. Management of atrial fibrillation. N Engl J Med 1992; 326:1264. https://doi.org/10.1056/NEJM199205073261906

Atrial fibrillation: current understandings and research imperatives. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. J Am Coll Cardiol 1993; 22:1830. https://doi.org/10.1016/0735-1097(93)90765-S

Lip GY, Metcalfe MJ, Rae AP. Management of paroxysmal atrial fibrillation. Q J Med 1993; 86:467. https://doi.org/10.1093/qjmed/86.8.467

Disch DL, Greenberg ML, Holzberger PT, et al. Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med 1994; 120:449. https://doi.org/10.7326/0003-4819-120-6-199403150-00001

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2; 64(21):e1-76.

Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997 Oct 7; 96(7):2455-61 https://doi.org/10.1161/01.CIR.96.7.2455

Lip GY, Beevers DG. ABC of atrial fibrillation: history, epidemiology, and importance of atrial fibrillation. BMJ. 1995 Nov 18; 311(7016):1361-3. https://doi.org/10.1136/bmj.311.7016.1361

Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001 Feb 6; 103(5):769-77. https://doi.org/10.1161/01.CIR.103.5.769

Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983 Aug; 106(2):389-96. https://doi.org/10.1016/0002-8703(83)90208-9

Captur G, Arbustini E, Bonne G, et al. Lamin and the heart. Heart. 2018 Mar; 104(6):468-479. https://doi.org/10.1136/heartjnl-2017-312338

Falk RH. Atrial fibrillation. N Engl J Med. 2001 Apr 5; 344(14):1067-78. https://doi.org/10.1056/NEJM200104053441407

Agarwal A, York M, Kantharia BK, et al. Atrial fibrillation: modern concepts and management. Annu Rev Med. 2005; 56:475-94. https://doi.org/10.1146/annurev.med.56.082103.104656

Peters NS, Schilling RJ, Kanagaratnam P, et al. Atrial fibrillation: strategies to control, combat, and cure. Lancet. 2002 Feb 16; 359(9306):593-603. https://doi.org/10.1016/S0140-6736(02)07748-6

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2; 64(21):e1-76.

Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001 Feb 6; 103(5):769-77. https://doi.org/10.1161/01.CIR.103.5.769

Nattel S, Shiroshita-Takeshita A, Brundel BJ, et al. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005 Jul-Aug; 48(1):9-28. https://doi.org/10.1016/j.pcad.2005.06.002

Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 57:223. https://doi.org/10.1016/j.jacc.2010.10.001

American College of Cardiology Foundation, American Heart Association, European Society of Cardiology, et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2013; 127:1916. https://doi.org/10.1161/CIR.0b013e318290826d

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130:e199. https://doi.org/10.1161/CIR.0000000000000041

January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 2019; 140:e125. https://doi.org/10.1161/CIR.0000000000000665

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42:373. https://doi.org/10.1093/eurheartj/ehaa612

National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. NG196. April 2021 [internet publication].

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021 Feb 1; 42(5):373-498. https://doi.org/10.1093/eurheartj/ehaa798

Chen LY, Norby FL, Gottesman RF, et al. Association of atrial fibrillation with cognitive decline and dementia over 20 Years: the ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J Am Heart Assoc. 2018 Mar 7; 7(6):e007301. https://doi.org/10.1161/JAHA.117.007301

European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31:2369. https://doi.org/10.1093/eurheartj/ehq278

Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017; 14:627. https://doi.org/10.1038/nrcardio.2017.153

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020 Aug 29 [Epub ahead of print].

Batra G, Svennblad B, Held C, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016 Jun 15; 102(12):926-33. https://doi.org/10.1136/heartjnl-2015-308678

Borre ED, Goode A, Raitz G, et al. Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review. Thromb Haemost. 2018 Dec; 118(12):2171-87. https://doi.org/10.1055/s-0038-1675400

Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov; 138(5):1093-10 https://doi.org/10.1378/chest.10-0134

Published

2022-08-15
Statistics
Abstract Display: 342
PDF Downloads: 427
PDF Downloads: 63

How to Cite

1.
Sharik M, Mubashir W, Ahad WA, Shafi A. Non-Valvular Atrial Fibrillation: A Systematic Review. J. Drug Delivery Ther. [Internet]. 2022 Aug. 15 [cited 2025 Nov. 14];12(4-S):232-5. Available from: https://www.jddtonline.info/index.php/jddt/article/view/5522

How to Cite

1.
Sharik M, Mubashir W, Ahad WA, Shafi A. Non-Valvular Atrial Fibrillation: A Systematic Review. J. Drug Delivery Ther. [Internet]. 2022 Aug. 15 [cited 2025 Nov. 14];12(4-S):232-5. Available from: https://www.jddtonline.info/index.php/jddt/article/view/5522